Tarsus Pharmaceuticals (TARS) Financials

Tarsus Pharmaceuticals Inc (TARS) provides its financial information through its income statement, balance sheet, and cash flow statement. The income statement shows the company's revenue, expenses, and net income from stockholders. It includes key metrics such as gross profit, EBIT (earnings before interest and taxes), and EBITDA (earnings before interest, taxes, depreciation, and amortization). Gross profit represents the difference between revenue and cost of goods sold, while EBIT reflects the company's operating income before interest and taxes. EBITDA further adjusts for non-cash expenses like depreciation and amortization. Net income from stockholders is the final profit amount distributed to shareholders after deducting all expenses and taxes.

The balance sheet of Tarsus Pharmaceuticals Inc (TARS) provides a snapshot of the company's financial position at a specific point in time. It includes the company's total assets, total liabilities, and stockholders' equity. Total assets represent the sum of the company's cash equivalents, investments, property, and other assets. Total liabilities include debts owed to creditors and other obligations. Stockholders' equity is the residual value of the company's assets after deducting liabilities and represents shareholders' ownership in the company. Net debt is a measure of the company's debt after subtracting its cash equivalents. It helps assess the company's ability to meet its financial obligations.

The cash flow statement of Tarsus Pharmaceuticals Inc (TARS) provides information about the company's cash inflows and outflows during a specific period. It includes three sections: operating cash flow, investing cash flow, and financing cash flow. Operating cash flow represents the cash generated from the company's core operations. Investing cash flow shows the cash used for acquiring or selling assets, such as property or equipment. Financing cash flow reflects the cash received or spent on financial activities, such as issuing or repurchasing stock, or borrowing or repaying debt. Free cash flow is the cash remaining after deducting capital expenditures from operating cash flow and is an important measure of the company's financial strength.